Want to join the conversation?
$AGN said in eye care, sales grew by 10% during 2Q16, driven by strength from RESTASIS and OZURDEX. OZURDEX delivered strong results globally with 30% growth in the US and 34% in international markets driven by its expanded diabetic macular edema label. In Aesthetics, sales grew by 14% driven by strong performance from Botox and fillers.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.